Research papers
Persistence
Clinical trials
Establishment of orally-administered Lactobacillus gasseri SBT2055SR in the gastrointestinal tract of humans and its influence on intestinal microflora and metabolism
S. Fujiwara, et al.
Journal of Applied Microbiology 2001, 90, 343-352
Stability
Toxicity Studies on Lactobacillus gasseri SBT2055 (LG2055) in Rats.
Imai E. et al.
Pharmacometrics Vol.60(5/6) pp. 131-150 2001
Stability
Bacterial Reverse Mutation Studies of Lactobacillus gasseri SBT2055 (LG2055)
Okada N. et al.
Pharmacometrics Vol.60(5/6) pp. 151-156 2001
Intestinal microflora
Milk Fermented with Yogurt Cultures and Lactobacillus gasseri SBT2055 (LG2055: strain Yukijirushi) Compared with Yogurt: Influence on Intestinal Microflora and Bowel Habits of Healthy Young Women.
Ishida Y. et al.
Pharmacometrics Vol.61(2/3) pp. 203-213 2001
Survival
Monitoring and Survival of Lactobacillus gasseri SBT2055 in the Human Intestinal Tract
Hidetoshi Takahashi,
Microbiol. Immunol., 50(11), 867-870, 2006
Effects of milk fermented by Lactobacillus gasseri SBT2055 on adipocyte size in rats
Masao Sato
British Journal of Nutrition (2008), 99, 1013-1017
Milk fermented by Lactobacillus gasseri SBT2055 influences adipocyte size via inhibition of dietary fat absorption in Zucker rats
Essam M. Hamad
British Journal of Nutrition (2009), 101, 716-724
Clinical trials
Regulation of abdominal adiposity by probiotics(Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial
Y Kadooka
European Journal of Clinical Nutrition (2010) 64, 636-643
The probiotic Lactobacillus gasseri SBT2055 inhibits enlargement of visceral adipocytes and upregulation of serum soluble adhesion molecule (sICAM-1) in rats
Y. Kadooka et al.
International Dairy Journal 21 (2011) 623-627
Clinical trials
Effect of Lactobacillus gasseri SBT2055 in fermented milk on abdominal adiposity in adults in a randomised controlled trial
Yukio Kadooka
British Journal of Nutrition (2013), 110, 1696-1703 doi:10.1017
Clinical trials
Visceral Fat-reducing Effect of Fermented Milk Containing the Probiotic Lactobacillus gasseri SBT2055.
Takano Y, et al.
Jpn. Pharmacol. Ther. 2013; 41(9): 895-903.
Stability
Clinical trials
Safety Evaluation of Excessive Intake of the Fermented Milk Containing the Probiotic Lactobacillus gasseri SBT2055
T. Kobayashi, et al.
Jpn. Pharmacol. Ther. 2013; 41(10): 989-997.
Clinical trials
Lactobacillus gasseri SBT2055 reduces postprandial and fasting serum non-esterified fatty acid levels in Japanese hypertriacylglycerolemic subjects
A. Ogawa et al.
Lipids in Health and Disease 2014, 13:36
Anti-obesity effect of Lactobacillus gasseri SBT2055 accompanied by inhibition of pro-inflammatory gene expression in the visceral adipose tissue in diet-induced obese mice
Miyoshi, M
Eur J Nutr (2014) 53, 599-606
Gastrointestinal health
Mouse Models for Assessing the Protective Efficacy of Lactobacillus gasseri SBT2055 against Helicobacter suis Infection Associated with the Development of Gastric Mucosa-Associated Lymphoid Tissue Lymphoma
Hidenori Matsui
Helicobacter, 20（4）, 291-298, （2015）
Administration of Lactobacillus gasseri SBT2055 suppresses macrophage infiltration into adipose tissue in diet-induced obese mice
Ken Ukibe
British Journal of Nutrition, 114, 1180-1187, (2015)
Gastrointestinal health
Cell surface-associated aggregation-promoting factor from Lactobacillus gasseri SBT2055 facilitates host colonization and competitive exclusion of Campylobacter jejuni
Nishiyama Keita
Molecular Microbiology, 98(4), 712-726, (2015)
Clinical trials
Lactobacillus gasseri SBT2055 suppresses fatty acid release through enlargement of fat emulsion size in vitro and promotes fecal fat excretion in healthy Japanese subjects
A. Ogawa et al.
Lipids in Health and Disease (2015) 14:20
Probiotic Lactobacillus gasseri SBT2055 improves glucose tolerance and reduces body weight gain in rats by stimulating energy expenditure
Bungo Shirouchi
British Journal of Nutrition (2016), 116, 451-458
Longevity and anti-aging
Effects and mechanisms of prolongevity induced by Lactobacillus gasseri SBT2055 in Caenorhabditis elegans
Hisako Nakagawa,
Aging Cell (2016) 15, pp227-236
Anti-inflammation
Lactobacillus gasseri SBT2055 inhibits adipose tissue inflammation and intestinal permeability in mice fed a high-fat diet
Michio Kawano
Journal of Nutritional Science, 5:e23, page 1 of 9, （2016）
Adhesion ability
In vitro investigation of molecules involved in Lactobacillus gasseri SBT2055 adhesion to host intestinal tract components
T.Arai,
Journal of Applied Microbiology, 120（6）, 1658-1667, （2016）
Probiotic Lactobacillus gasseri SBT2055 improves glucose tolerance and reduces body weight gain in rats by stimulating energy expenditure
Bungo Shirouchi
British Journal of Nutrition, 116, 451-458, （2016）
Immunity
Clinical trials
Lactobacillus gasseri SBT2055 Stimulates Immunoglobulin Production and Innate Immunity after Influenza Vaccination in Healthy Adult Volunteers
Jun Nishihira
Functional Foods in Health and Disease, 6(9), 544-568, (2016)
Against oxidative stress
Protective Effects and Functional Mechanisms of Lactobacillus gasseri SBT2055 against Oxidative Stress
Eiji Kobatake
PLOS ONE, 12(5), :e0177106, (2017)
Oral health
Oral administration of Lactobacillus gasseri SBT2055 is effective in preventing Porphyromonas gingivalis-accelerated periodontal disease
R. Kobayashi,
Scientific Reports volume 7, Article number: 545 (2017)
Immunity
Clinical trials
Intake of Lactobacillus paragasseriSBT2055 improves subjective symptoms of common cold during winter season in healthy adults: A randomized, double-blind, placebo-controlled parallel-group comparative study.
Kobatake,
Front. Nutr. 2022, 9, 1063584(2022).
Immunity
Clinical trials
Lactobacillus paragasseriSBT2055 Activates PlasmacytoidDendritic Cells and Improves Subjective Symptoms of Common Cold in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Parallel-Group Comparative Trial.
Eiji Kobatake.
Trial.Nutrients. Oct 20;15(20):4458 (2023).
Gut health
Clinical trials
Safety
Effects of Lactobacillus paragasseri SBT 2055 on intestinal environment and safety in healthy subjects -a randomized, double-blind, placebo-controlled, parallel-group comparative method-.
Tsukahara.
Pharmacometrics, 105, 1/2,7 (2023).
Gut health
Clinical trials
Effects of Lactobacillus paragasseri SBT 2055 on improving defecation -a randomized, double-blind, placebo-controlled, parallel-group comparative study.
Obuchi.
Jpn Pharmacol Ther, 51, 9, 1365 (2023).